Transaction DateRecipientSharesTypePriceValue
16th September 2020Sciences Llc Tardi Med100,694Open or private sale$1.03$103,694.68
15th September 2020Sciences Llc Tardi Med87,060Open or private sale$1.03$89,549.92
14th September 2020Sciences Llc Tardi Med455Open or private sale$1.03$468.65
11th September 2020Sciences Llc Tardi Med7,483Open or private sale$1.03$7,709.73
10th September 2020Sciences Llc Tardi Med32,943Open or private sale$1.04$34,379.31
18th May 2020Sciences Llc Tardi Med5,666,152Other acquisition or disposition$0.00
17th April 2020Capital Viii, Llc Vivo10,265Open or private sale$15.40$158,081.00
17th April 2020Capital Viii, Llc Vivo74,333Open or private sale$15.40$1,144,728.20
16th April 2020Capital Viii, Llc Vivo3,663Open or private sale$15.20$55,677.60
16th April 2020Capital Viii, Llc Vivo26,527Open or private sale$15.20$403,210.40
Bio Pharm X
Bio Pharm X logo

BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010.

Ticker: BPMX
Sector: Producer Manufacturing
Industry: Miscellaneous Manufacturing
SEC Central Index Key (CIK): 1504167
Employees: 3
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals